Page last updated: 2024-08-22

1-phenyl-3,3-dimethyltriazene and Macular Degeneration

1-phenyl-3,3-dimethyltriazene has been researched along with Macular Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hata, M; Kameda, T; Kojima, H; Kurimoto, Y; Mandai, M; Miyamoto, N1

Other Studies

1 other study(ies) available for 1-phenyl-3,3-dimethyltriazene and Macular Degeneration

ArticleYear
[Five-year visual outcomes of typical age-related macular degeneration and/or polypoidal choroidal vasculopathy patients who received photodynamic therapy (PDT) as initial treatment in comparison with patients prior to the PDT era].
    Nippon Ganka Gakkai zasshi, 2012, Volume: 116, Issue:10

    Topics: Age Factors; Aged; Aged, 80 and over; Choroid; Choroid Diseases; Female; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Treatment Outcome; Triazenes; Visual Acuity

2012